EP1599193A4 - Verfahren zur behandlung von hypothyreoidismus - Google Patents

Verfahren zur behandlung von hypothyreoidismus

Info

Publication number
EP1599193A4
EP1599193A4 EP04709106A EP04709106A EP1599193A4 EP 1599193 A4 EP1599193 A4 EP 1599193A4 EP 04709106 A EP04709106 A EP 04709106A EP 04709106 A EP04709106 A EP 04709106A EP 1599193 A4 EP1599193 A4 EP 1599193A4
Authority
EP
European Patent Office
Prior art keywords
treating hypothyroidism
hypothyroidism
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04709106A
Other languages
English (en)
French (fr)
Other versions
EP1599193A2 (de
Inventor
Irwin Klein
Kaie Ojamaa
Sara Danzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Shore Long Island Jewish Research Institute
Original Assignee
North Shore Long Island Jewish Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Shore Long Island Jewish Research Institute filed Critical North Shore Long Island Jewish Research Institute
Publication of EP1599193A2 publication Critical patent/EP1599193A2/de
Publication of EP1599193A4 publication Critical patent/EP1599193A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP04709106A 2003-02-11 2004-02-06 Verfahren zur behandlung von hypothyreoidismus Withdrawn EP1599193A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US364800 2003-02-11
US10/364,800 US20040156893A1 (en) 2003-02-11 2003-02-11 Method for treating hypothyroidism
PCT/US2004/003620 WO2004071432A2 (en) 2003-02-11 2004-02-06 Method for treating hypothyroidism

Publications (2)

Publication Number Publication Date
EP1599193A2 EP1599193A2 (de) 2005-11-30
EP1599193A4 true EP1599193A4 (de) 2007-04-04

Family

ID=32824502

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04709106A Withdrawn EP1599193A4 (de) 2003-02-11 2004-02-06 Verfahren zur behandlung von hypothyreoidismus

Country Status (9)

Country Link
US (2) US20040156893A1 (de)
EP (1) EP1599193A4 (de)
JP (1) JP2006517588A (de)
AU (1) AU2004211961B2 (de)
BR (1) BRPI0407410A (de)
CA (1) CA2515400A1 (de)
CO (1) CO5650242A2 (de)
NO (1) NO20054034L (de)
WO (1) WO2004071432A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
US10150792B2 (en) * 2010-11-08 2018-12-11 Synthonics, Inc. Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
US10695309B2 (en) 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
JP2023526502A (ja) * 2020-05-21 2023-06-21 イクイリブレイト セラピューティクス， エルエルシー 甲状腺ホルモンレベルを制御するためのマイクロニードルデバイス

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550108A1 (de) * 1991-12-30 1993-07-07 Akzo Nobel N.V. Thyroaktive Zusammensetzung mit kontrollierter Freigabe
US20030194437A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Cmax properties

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577535A (en) * 1966-06-29 1971-05-04 Armour Pharma Treatment of thyroid hormone impairment pharmaceutical compositions containing 3,5,3' -l-triiodothyronine complexes
US3477954A (en) * 1966-06-29 1969-11-11 Armour Pharma Phosphonium iodide complexes of thyroxine,methods of preparing same,and methods of preparing 3,5,3'-l-triiodothyronine therefrom
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
US3689669A (en) * 1970-10-09 1972-09-05 Univ Of North Carolina The Antidepressant method and composition
US3928553A (en) * 1972-03-23 1975-12-23 Univ New York Radioimmunoassay method for triiodothyronine and thyroxine
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
US6288117B1 (en) * 2000-03-23 2001-09-11 North Shore-Long Island Jewish Research Institute Method for treating congestive heart failure
US20020183882A1 (en) * 2000-10-20 2002-12-05 Michael Dearing RF point of sale and delivery method and system using communication with remote computer and having features to read a large number of RF tags

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550108A1 (de) * 1991-12-30 1993-07-07 Akzo Nobel N.V. Thyroaktive Zusammensetzung mit kontrollierter Freigabe
US20030194437A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Cmax properties

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAMILTON MICHELE A ET AL: "Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure", AMERICAN JOURNAL OF CARDIOLOGY, CAHNERS PUBLISHING CO., NEWTON, MA,, US, vol. 81, no. 4, 15 February 1998 (1998-02-15), pages 443 - 447, XP002357179, ISSN: 0002-9149 *

Also Published As

Publication number Publication date
CA2515400A1 (en) 2004-08-26
EP1599193A2 (de) 2005-11-30
US20050176829A1 (en) 2005-08-11
CO5650242A2 (es) 2006-06-30
JP2006517588A (ja) 2006-07-27
NO20054034L (no) 2005-10-05
AU2004211961A1 (en) 2004-08-26
WO2004071432A2 (en) 2004-08-26
US20040156893A1 (en) 2004-08-12
BRPI0407410A (pt) 2006-02-21
AU2004211961B2 (en) 2009-04-23
NO20054034D0 (no) 2005-08-30
WO2004071432A3 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
IL164352A0 (en) Methods for treating tweak-related conditions
IL179139A0 (en) Method for treating multiple sclerosis
IL175818A0 (en) Method for treating adamts-5- associated disease
HK1074778A1 (zh) 治療肥胖症的方法
AU2003272713A8 (en) A method for treating severe tinnitus
EP1581234A4 (de) Verfahren zur behandlung von migräne
EP1675596A4 (de) Verfahren
EP1497856A4 (de) Ashing-verfahren
EP1732394A4 (de) Wasserentzug-bratverfahren
GB0301117D0 (en) Method
GB0301972D0 (en) Method for identifying novel treatments
PL376932A1 (pl) Sposób traktowania żużla
IL150501A0 (en) Method for wagering
EP1599193A4 (de) Verfahren zur behandlung von hypothyreoidismus
AU2003253813A8 (en) Method for colpoplasty
EP1701920A4 (de) Verfahren zur behandlung von haltigen lösungen
AU2003299652A8 (en) Methods for treating diabetes
GB0307544D0 (en) Treatment method
AU2003213109A8 (en) Method for treating cellulite
GB0304215D0 (en) Method for treating waste
GB0302691D0 (en) Treatment method
AU2003251208A8 (en) Apparatus for treating strip-shaped parts
EP1681922A4 (de) Verfahren zur behandlung von fusspilz
GB0304632D0 (en) Method
EP1612264A4 (de) Organformverfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050905

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070306

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 5/14 20060101ALI20070228BHEP

Ipc: A61K 31/198 20060101AFI20070228BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110829